2-Bromo-1-[4-(methylsulfonyl)phenyl]-1-ethanonum
![2-Bromo-1-[4-(methylsulfonyl)phenyl]-1-ethanone Imago Proposita](https://cdn.globalso.com/jingyepharma/50413-24-6.jpg)
Synonyma:2-BROMO-4'-(METHYLSULFONYL)ACETOPHENONUM, 2-BROMO-1-[4-(METHYLSULFONYL)PHENYL]-1-ETHANONUM; 4-METHYLSULFONYL-A-BROMOACETOPYENONUM; 4-METHYLSULFONYL-A-BROMOACETOPHENONUM; 4-METHYLSULFONYLALPHA-BROMOACETOPHENONUM; 4-(METHYLSULFONYL)PHENACYLBROMIDUM; ALPHA-BROMO-4-METHYLSULFONYLACETOPHENONUM; 4-METHYLSULFONYL-ALPHA-BROMOACETOPHENONUM; 2-BROMO-4'-(METHYLSULFONYL)ACETOPHENONUM.
Numerus CAS:50413-24-6
Formula Molecularis:C9H9BrO3S.
Pondus Moleculare:277.14
Usus:Composita carbonylica
Applicatio:Pharmaceutica, intermedia, API, synthesis consuetudinaria, chemica
Structura
Superioritas:Optimus Venditor, Alta Qualitas, Pretium Competitivum, Celeris Traditio, Celeris Responsio
Categoriae conexae:Substantia medicamenti; Cetonum; Intermedia pharmaceutica; Intermedia organica; Intermedia chemica; Halogenida acetylorum; Phenyl et Phenyl-Het; Halogenida acetylorum; Phenyl et Phenyl-Het
| Punctum fusionis | 126°C |
| Punctum ebullitionis | 428.4±41.0°C (Praedictum) |
| Densitas | 1.575±0.06 g/cm³ (Praedictum) |
| Conditio repositionis | In loco obscuro, atmosphaera inerti, temperatura ambiente servandum. |
| Codex Categoriae Periculi | XXXIV-XXXVI |
| Declarationes Salutis | XXVI-XXXVI/XXXVII/XXXIX-XLV |
| Transportatio rerum periculosarum Non | 3261 |
| Nota Periculi | Corrosivus |
| Gradus periculi | Irritans |
| Categoria involucri | II |
| Specificationes speciales secundum requisita emptoris | |
| Aspectus | Pulvis crystallinus pallide flavus ad album |
| Puritas (HPLC) | 98.0% min. |
Cautelae ad tutum tractandum:
Loco bene ventilato tractandum. Vestes tutelares idoneas gere. Contactum cum cute et oculis vita. Formationem pulveris et aerosolorum vita. Instrumenta non scintillantia utere. Ignem vapore electrostatico excitatum prohibe.
Conditiones ad tutam reponendum, inter quaslibet incompatibilitates:
Vasculum arcte clausum in loco sicco, frigido et bene ventilato serva. Seorsum a vasis cibariis vel materiis incompatibilibus serva.
Jingye octoginta sex reactorum series in summa habet, quorum volumen reactoris smaltati est sexaginta novem, a quinquaginta ad tria milia litrorum. Numerus reactorum inoxidabilium est duodeviginti, a quinquaginta ad tria milia litrorum. QC centum instrumentis analyticis omnis generis instructum est. Productionem commercialem et analysin comprehensivam producti satisfacere potest. Hoc productum est productum singulare praestans et secundum necessitates emptoris tradi potest.
Societas Jiangsu Jingye Pharmaceutical Co., Ltd., olim Jintan Depei Chemical Co., Ltd., anno 1994 condita, anno 2016 in fabricam pharmaceuticam professionalem conversa est. Post duo decennia progressionis, Jingye Pharmaceutical in societatem pharmaceuticam professionalem et comprehensivam crevit, investigationem et progressionem (R&D), productionem, importationem et exportationem cum duabus subsidiariis Shanghaii et Lianyungang sitis coniungens.